Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Industry: Medical Instruments & Sup...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Medical is Zen Rated B and is the 38th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
INFU	INFUSYSTEM HOLDINGS INC	$191.64M	11.90%	6.60%	14.83%	12.00%	0.75	1.80	56.00%	4.60%	8.31%
EMBC	EMBECTA CORP	$537.12M	-20.90%	12.60%	36.12%	14.40%	-2.74	2.64	63.10%	12.90%	27.73%
NVST	ENVISTA HOLDINGS CORP	$4.40B	1.50%	0.80%	4.43%	9.60%	0.83	2.38	54.70%	1.70%	7.86%
ATRC	ATRICURE INC	$1.50B	-2.40%	-1.80%	-0.75%	-2.10%	0.33	3.96	75.00%	-2.10%	-0.80%
KRMD	KORU MEDICAL SYSTEMS INC	$210.77M	-22.40%	-13.90%	-19.16%	-26.70%	0.65	2.48	62.30%	-9.50%	-9.45%
LMAT	LEMAITRE VASCULAR INC	$2.45B	15.60%	9.80%	13.87%	13.10%	0.57	12.89	71.50%	23.10%	32.20%
MMSI	MERIT MEDICAL SYSTEMS INC	$4.32B	8.50%	5.00%	8.07%	10.70%	0.70	4.34	48.70%	8.50%	13.02%
HBIO	HARVARD BIOSCIENCE INC	$24.52M	-199.40%	-59.10%	-212.66%	-120.60%	4.54	0.81	56.90%	-61.60%	-57.43%
HAE	HAEMONETICS CORP	$2.98B	20.30%	7.10%	12.87%	14.10%	1.73	1.75	59.40%	13.30%	19.05%
WST	WEST PHARMACEUTICAL SERVICES INC	$17.71B	16.70%	12.40%	17.03%	20.60%	0.34	3.02	35.90%	16.10%	20.03%
BLFS	BIOLIFE SOLUTIONS INC	$959.24M	-1.30%	-1.20%	-1.89%	-5.50%	0.09	5.94	64.60%	-4.80%	-7.54%
COO	COOPER COMPANIES INC	$14.94B	4.80%	3.20%	6.48%	8.60%	0.49	1.34	65.40%	9.70%	16.90%
RMD	RESMED INC	$36.84B	24.80%	18.30%	24.80%	56.30%	0.35	3.06	60.90%	27.50%	33.34%
ICUI	ICU MEDICAL INC	$3.26B	0.00%	0.00%	2.43%	3.40%	0.91	2.39	36.80%	0.00%	3.86%
ALC	ALCON INC	$39.64B	4.40%	3.10%	4.78%	9.70%	0.43	2.12	55.20%	9.40%	13.11%
BLCO	BAUSCH & LOMB CORP	$6.04B	-5.60%	-2.60%	0.79%	1.10%	1.16	1.55	59.80%	-7.10%	1.88%
ANGO	ANGIODYNAMICS INC	$446.38M	-15.30%	-10.10%	-14.46%	-32.60%	0.53	2.24	54.60%	-9.00%	-9.30%
XRAY	DENTSPLY SIRONA INC	$2.54B	-35.20%	-10.30%	-9.74%	-10.00%	3.05	1.51	50.00%	-16.30%	-10.82%
AZTA	AZENTA INC	$1.12B	-3.40%	-2.80%	-4.97%	-11.70%	0.21	2.92	44.60%	-9.70%	-15.11%
SMTI	SANARA MEDTECH INC	$168.62M	-127.50%	-42.30%	-58.21%	-53.10%	10.56	1.80	92.30%	-36.80%	-30.69%
UTMD	UTAH MEDICAL PRODUCTS INC	$208.62M	9.90%	9.50%	12.29%	74.40%	0.03	32.06	57.10%	30.10%	37.84%
PDEX	PRO DEX INC	$145.20M	29.30%	18.00%	32.20%	26.90%	0.50	4.03	28.30%	15.70%	22.35%
ISRG	INTUITIVE SURGICAL INC	$174.07B	16.40%	14.40%	17.83%	23.80%	0.14	4.88	66.00%	28.40%	32.70%
BDX	BECTON DICKINSON & CO	$47.59B	6.90%	3.20%	5.60%	8.90%	1.17	1.05	46.10%	8.00%	11.77%
STVN	STEVANATO GROUP SPA	$4.67B	9.70%	5.80%	10.55%	9.80%	0.71	1.76	29.00%	11.80%	17.85%
BAX	BAXTER INTERNATIONAL INC	$9.10B	-13.80%	-4.60%	-1.90%	-2.10%	2.28	2.31	30.10%	-8.50%	-2.88%
RGEN	REPLIGEN CORP	$6.76B	2.40%	1.70%	2.98%	6.60%	0.40	8.37	52.30%	6.60%	11.36%
MDLN	MEDLINE INC	$57.58B	8.60%	3.10%	5.73%	8.00%	1.79	4.29	26.40%	4.10%	7.25%
ATR	APTARGROUP INC	$8.50B	14.70%	8.00%	13.32%	20.50%	0.96	1.62	37.20%	10.40%	14.41%
NNNN	ANBIO BIOTECHNOLOGY	$3.29B	11.20%	11.00%	9.34%	17.00%	0.01	211.10	89.70%	37.20%	37.20%
WRBY	WARBY PARKER INC	$3.04B	0.50%	0.20%	-0.93%	-1.00%	0.96	2.35	54.00%	0.20%	-0.61%
EKSO	EKSO BIONICS HOLDINGS INC	$40.55M	-110.50%	-50.70%	-99.22%	-101.40%	1.23	1.63	53.50%	-91.40%	-88.96%
BNGO	BIONANO GENOMICS INC	$11.40M	-86.40%	-49.80%	-68.74%	-66.70%	0.59	2.12	46.00%	-134.40%	-134.24%
FEMY	FEMASYS INC	$30.99M	-764.20%	-142.00%	-310.90%	-224.20%	2.58	1.16	63.10%	-960.50%	-866.93%
PLSE	PULSE BIOSCIENCES INC	$1.23B	-73.50%	-63.70%	-84.03%	-750.30%	0.17	10.53	-54.00%	-20,794.60%	-20,794.57%
TFX	TELEFLEX INC	$5.01B	-23.70%	-12.30%	-13.57%	-20.80%	1.22	2.54	56.20%	-45.40%	-42.12%
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$602.84M	-528.40%	-267.60%	-5,792.55%	3,181.00%	-250.00	0.73	70.30%	-4,921.30%	-4,917.46%
STSS	SHARPS TECHNOLOGY INC	$50.52M	-90.80%	-85.70%	-23.60%	-94.60%	0.03	3.74	-718.70%	-34,070.10%	-33,385.77%
STXS	STEREOTAXIS INC	$191.32M	-597.20%	-55.60%	-93.69%	-298.10%	5.44	1.31	53.10%	-82.80%	-78.56%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$1.34B	-198.60%	-60.60%	-58.75%	-180.50%	0.50	5.47	46.40%	-186.90%	-166.90%
MBOT	MICROBOT MEDICAL INC	$159.84M	-37.10%	-34.40%	-16.58%	-41.60%	0.05	27.53	N/A	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$228.83M	-15.60%	-13.30%	-15.12%	-44.50%	0.17	7.03	40.40%	-47.90%	-46.05%
AGPU	AXE COMPUTE INC	$6.21M	N/A	-1,937.20%	110.46%	475.60%	-1.04	0.01	50.20%	-11,581.30%	-11,581.34%
GCTK	GLUCOTRACK INC	$1.38M	-2,659.20%	-303.80%	-907.48%	1,929.70%	2.01	1.53	N/A	N/A	N/A
MLSS	MILESTONE SCIENTIFIC INC	$22.09M	-164.80%	-75.30%	-192.55%	-210.60%	2.33	1.61	71.90%	-74.70%	-74.45%
NEPH	NEPHROS INC	$41.13M	15.80%	12.20%	14.00%	26.20%	0.32	4.34	63.20%	8.30%	8.42%
NXGL	NEXGEL INC	$9.36M	-55.30%	-26.90%	-34.10%	-37.40%	1.17	1.69	38.30%	-24.70%	-24.29%
NYXH	NYXOAH SA	$140.42M	-101.30%	-66.40%	-101.28%	-137.00%	0.84	1.70	64.40%	-1,484.70%	-1,308.30%
RGNT	REGENTIS BIOMATERIALS LTD	$17.40M	N/A	-337.00%	-287.69%	1,188.30%	0.61	2.65	N/A	N/A	N/A
RVP	RETRACTABLE TECHNOLOGIES INC	$20.93M	-8.40%	-4.40%	-4.43%	-4.40%	0.91	6.66	-2.40%	-17.60%	-15.99%
POCI	PRECISION OPTICS CORPORATION INC	$33.58M	-60.60%	-32.70%	-52.00%	-102.60%	1.45	1.05	9.70%	-28.30%	-27.57%
STAA	STAAR SURGICAL CO	$914.01M	-23.20%	-17.80%	-21.47%	-33.10%	0.31	4.55	76.20%	-33.60%	-34.36%
HOLX	HOLOGIC INC	$16.91B	11.00%	6.10%	9.45%	17.80%	0.75	4.04	51.50%	13.20%	18.84%
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$22.70M	4.10%	2.40%	4.75%	4.00%	0.80	1.86	29.20%	5.80%	6.80%
ZTEK	ZENTEK LTD	$70.00M	-61.30%	-45.40%	-58.04%	-56.00%	0.41	1.00	57.10%	-857.10%	-865.02%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$8.22M	-139.10%	-45.20%	-36.10%	-1,570.70%	0.41	3.58	-69.20%	-9,335.70%	-9,305.22%
LUCY	INNOVATIVE EYEWEAR INC	$5.72M	-82.30%	-76.80%	-76.26%	-219.10%	0.09	11.98	22.80%	-328.00%	-327.98%

Medical Stocks FAQ

What are the best medical stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical stocks to buy right now are:

1. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #1 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 45, which is 14 points higher than the medical industry average of 31.

INFU passed 14 out of 33 due diligence checks and has strong fundamentals. Infusystem Holdings has seen its stock return 51.68% over the past year, overperforming other medical stocks by 62 percentage points.

Infusystem Holdings has an average 1 year price target of $15.00, an upside of 58.23% from Infusystem Holdings's current stock price of $9.48.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: B, Momentum: D, Sentiment: C, Safety: C, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 43, which is 12 points higher than the medical industry average of 31.

EMBC passed 15 out of 38 due diligence checks and has strong fundamentals. Embecta has seen its stock lose -29.58% over the past year, underperforming other medical stocks by -19 percentage points.

Embecta has an average 1 year price target of $25.00, an upside of 175.63% from Embecta's current stock price of $9.07.

Embecta stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Envista Holdings (NYSE:NVST)

Envista Holdings (NYSE:NVST) is the #3 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Envista Holdings (NYSE:NVST) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: A, Financials: C, and AI: C.

Envista Holdings (NYSE:NVST) has a Due Diligence Score of 39, which is 8 points higher than the medical industry average of 31.

NVST passed 12 out of 33 due diligence checks and has average fundamentals. Envista Holdings has seen its stock return 50.64% over the past year, overperforming other medical stocks by 61 percentage points.

Envista Holdings has an average 1 year price target of $27.71, an upside of 3.18% from Envista Holdings's current stock price of $26.86.

Envista Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Envista Holdings, 28.57% have issued a Strong Buy rating, 0% have issued a Buy, 71.43% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 6.62%, which is 4 percentage points higher than the medical industry average of 2.24%.

Embecta's dividend payout ratio of 25.1% indicates that its high dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.02%, which is 3 percentage points higher than the medical industry average of 2.24%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -21.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Becton Dickinson & Co (NYSE:BDX)

Becton Dickinson & Co (NYSE:BDX) has an annual dividend yield of 2.5%, which is the same as the medical industry average of 2.24%. Becton Dickinson & Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Becton Dickinson & Co's dividend has shown consistent growth over the last 10 years.

Becton Dickinson & Co's dividend payout ratio of 68% indicates that its dividend yield is sustainable for the long-term.

Why are medical stocks down?

Medical stocks were down -1.53% in the last day, and down -4.61% over the last week. Cooper Companies was the among the top losers in the medical instruments & supplies industry, dropping -4.55% yesterday.

The Cooper Companies shares are trading lower after the stock reported mixed Q1 financial results. The stock reversed from yesterday's rally after the market closed.

What are the most undervalued medical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 62 points higher than the medical industry average of 24. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -29.58% in the past year. It has underperformed other stocks in the medical industry by -19 percentage points.

2. Haemonetics (NYSE:HAE)

Haemonetics (NYSE:HAE) is the second most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Haemonetics has a valuation score of 57, which is 33 points higher than the medical industry average of 24. It passed 4 out of 7 valuation due diligence checks.

Haemonetics's stock has dropped -4.57% in the past year. It has overperformed other stocks in the medical industry by 6 percentage points.

3. Harvard Bioscience (NASDAQ:HBIO)

Harvard Bioscience (NASDAQ:HBIO) is the third most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harvard Bioscience has a valuation score of 14, which is -10 points higher than the medical industry average of 24. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates HBIO a Valuation Rating of "B".

Harvard Bioscience's stock has dropped -33.73% in the past year. It has underperformed other stocks in the medical industry by -23 percentage points.

Are medical stocks a good buy now?

47.5% of medical stocks rated by analysts are a buy right now. On average, analysts expect medical stocks to rise by 25.36% over the next year.

11.63% of medical stocks have a Zen Rating of A (Strong Buy), 23.26% of medical stocks are rated B (Buy), 46.51% are rated C (Hold), 11.63% are rated D (Sell), and 6.98% are rated F (Strong Sell).

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is -438.87x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Infusystem Holdings (NYSEMKT:INFU)

2. Embecta (NASDAQ:EMBC)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Becton Dickinson & Co (NYSE:BDX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Harvard Bioscience (NASDAQ:HBIO)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareMedical Instruments & SuppliesBest Medical Stocks to Buy Now (2026)Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Infusystem Holdings (NYSEMKT:INFU)

2. Embecta (NASDAQ:EMBC)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Becton Dickinson & Co (NYSE:BDX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Harvard Bioscience (NASDAQ:HBIO)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.